Milestone Scientific (MLSS) Announces Marketing of Arjan Haverhals to CEO


Get inside Wall Street with StreetInsider Top quality. Claim your 1-week totally free trial right here.


Milestone Scientific Inc. (NYSE: MLSS), a foremost developer of computerized drug shipping instruments that supply painless and precise injections, these days introduced that in relationship with the Company’s formerly disclosed succession program: Leonard Osser announced his intention to resign as Interim Main Govt Officer the Board of Administrators has promoted Jan Adriaan (Arjan) Haverhals, President of the Firm, to also serve as Main Govt Officer of Milestone Scientific and Leonard Osser has been elected Vice Chairman of the Board of Directors of the Enterprise – each individual powerful May well 19, 2021. The Business is also happy to announce that it has appointed Scott Kahn as Main Financial Officer, efficient May 24, 2021. Mr. Kahn will triumph Joseph D’Agostino who retired from Milestone Scientific past month.

Leonard Osser, Interim CEO of Milestone Scientific, mentioned, “I am pretty pleased to announce Arjan’s marketing to CEO of Milestone Scientific. It is effectively deserved as Arjan has been instrumental in utilizing profitable income and marketing things to do all-around the dental instrument and accelerating the commercialization of CompuFlo® and CathCheck™. Arjan’s potent leadership will be a must have as we do the job in direction of our goal of creating our engineering as regular of care in epidural procedures throughout labor and shipping, all over the world. Furthermore, we are pleased to welcome Scott Kahn to the administration team. Scott provides extra than 40 several years of management with a tested observe document in company and finance and operations. His deep practical experience and sturdy monitor document as a CFO of numerous pharmaceutical and health care unit companies will be significant as we grow our firm and grow our international footprint. I glance ahead to playing an lively role in the advancement and results of the Organization likely ahead.”

“The Business and Board of Directors would like to convey our sincere gratitude to Leonard Osser for his sizeable contributions and remarkable leadership he offered Milestone over the decades,” stated Leslie Bernhard, Chairman of the Board of Milestone Scientific. “Len has executed on a concentrated vision of advancing and delivering Milestone’s computerized drug shipping instruments to market place and we appear ahead to continuing to advantage from his thoughtful counsel and active involvement in the Enterprise as the Vice Chairman of the Board. In addition, Leonard Osser will go on as Managing Director of China Operations. We have been getting ready this transition for some time and appear forward to Arjan’s participation in his new purpose as CEO as we put together for the future stage of our expansion.”

About Arjan Haverhals

Mr. Haverhals has served as Milestone Scientific’s President because September 2020 and as President and Chief Govt Officer of Milestone Scientific’s Dental Division, Wand Dental Inc., since June 2020. He provides much more than 30 yrs of revenue, marketing, merchandise enhancement, and international growth expertise in just the professional medical gadget, pharmaceutical, and other industries. Prior to becoming a member of the Enterprise, Mr. Haverhals was Senior Vice President of Income at Xcentric Mildew & Engineering, exactly where he was instrumental in rising revenue productiveness and efficiency for the firm’s prototype injection molding services, which bundled foremost healthcare company clientele. Previously, at Straumann, LLC, a world wide chief in production health care and dental units with more than $1 billion in profits, he held a series of senior income and marketing roles which includes Vice President of purchaser promoting & training, exactly where he oversaw all product or service franchises and led the launch of more than 30 products and solutions in the North American marketplace, ensuing in double-digit advancement. He also served as Senior Vice President for the Nordic Area at Straumann AB, Senior Vice President of World Revenue Electronic Methods, which integrated oversight of the strategic acquisition of Etkon and served as Vice President of the Prosthetics Organization Unit, in which he introduced a new implant and prosthetics solution line in a new current market section. He also served as Vice President of Global Marketing and advertising & Product sales at Elkem AS, one of Norway’s biggest industrial firms. Earlier, Mr. Haverhals served as Executive Vice President of Marketing & Product sales at Cresco Ti Methods Sàrl, a world dental implant enterprise, where he was accountable for turning all around and running world profits, internet marketing, and global business enterprise, the place he attained about 100{14cc2b5881a050199a960a1a3483042b446231310e72f0dc471a7a1eddd6b0c3} return on financial investment for shareholders. Mr. Haverhals holds an MS in Pharmacy from the University of Leyden in the Netherlands.

About Scott Kahn

Scott Kahn is a seasoned financial leader with over 4 a long time of knowledge in assorted corporations from Fortune 500 companies to get started-ups. Prior to becoming a member of Milestone Scientific, Mr. Kahn served as CFO and Vice President at Diopsys since July 2006 the place he was accountable for all accounting, finance, human means and investor relations. Prior to becoming a member of Diopsys, Mr. Kahn served as CFO at Diamond Chemical Co., Inc., a privately held chemical producer. Prior to becoming CFO at Diamond Chemical Co. Inc., Mr. Kahn was a Corporate Controller of Pharmaceutical Formulations, Inc., a publicly traded pharmaceutical company. Formerly, Mr. Kahn held a variety of finance, tactic and operational management roles. Mr. Kahn received a B.A. in Accounting from Franklin and Marshall School and an M.B.A. in Intercontinental Business from Rutgers College. He is a Accredited Public Accountant licensed in the Point out of New York.